Catalyst Wire Dossier Catalyst Wire Dossier

Neparvis

sacubitril/valsartan · Novartis Europharm Limited
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Neparvis, covering 2026-01-13 to 2026-01-13. Get the full timeline:

Most recent: EMA Authorised: Neparvis (sacubitril;valsartan) — Novartis Europharm Limited

See pricing